Organizations collaborate to develop international von Willebrand Disease guidelines
The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World
Read morenews, journals and articles from all over the world.
The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World
Read moreNew NCCN guidelines for patients: Survivorship series provides expert advice to help cancer survivors sustain better health while monitoring for any long-term side effects or recurrences
Read moreOne of the physiopathological characteristics of COVID-19 that has most baffled the scientific and medical community is what is known as “silent hypoxemia” or “happy hypoxia”.
Read moreLimited rejuvenation of aged hematopoietic stem cells in young bone marrow niche
Read moreThe ASH Research Collaborative and International Society on Thrombosis and Haemostasis define thrombosis-related endpoints to inform COVID-19 clinical trial design
Read moreCleveland Clinic research team publishes findings in Blood Cancer Discovery
Read moreSysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.
Read moreIn a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphocytic leukaemia.
Read moreProtein therapies are often more potent and selective toward their biochemical targets than other types of drugs, particularly small molecules.
Read morePeer Reviewed – Survey – Humans
Read moreResearchers at Children’s Hospital of Philadelphia (CHOP) have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19. They also found that a high proportion of children with SARS-CoV-2 infection met clinical and diagnostic criteria for thrombotic microangiopathy (TMA). TMA is a syndrome that involves clotting in the small blood vessels and has been identified as a potential cause for severe manifestations of COVID-19 in adults.
Read moreHaematopoietic stem cell scarcity is one of the biggest barriers to the development of new and improved treatments for blood cancers and disorders
Read more